Population-based study of autoimmune hepatitis and primary biliary cholangitis in Germany: rising prevalences based on ICD codes, yet deficits in medical treatmentautoimmune hepatitisprimary biliary cholangitisGermanytreatmentprevalenceBackground Population-based data on the prevalence of and real-life ...
unspecified 453.40 Acute embolism and thombos unspec 462 Acute pharyngitis 472.0 Chronic rhinitis 477.0 Allergic rhinitis due to pollen 9/10/15 ICD10 Code ICD10 Desc B20 HIV Disease B18.2 Chronic viral hepatitis c C50.919 Malignant neoplasm of unsp site of unspecified female breast C56.9 Malignant...
Hepatitis C virus–related mortality was classified using the ICD-10 code for acute viral hepatitis C (B17.1) or chronic viral hepatitis C (B18.2) as an underlying or multiple cause of death (n = 261 858). We earlier demonstrated that although HCV is underreported on death certificate...
aMethods: Patients who had at least one outpatient visit or admission with ICD-9-CM diagnosis code [translate] aBack in a minute Back in a minute [translate] aPsoriasis who had not. The cases were matched in a 1:4 ratio with controls from a sample cohort of 997,771 [translate] a...
nI,nccacdDdNitAionp,rocvcicdDeNs aAlopnrgo-vliivdeeds reapolosnitgo-rlyivfeodr trhepe ovsiritaolrgyefnoertitchienvfoirraml agteionne,titchiunsforerpmraetsieonnt,inthguths eremporelesceunltainrgpethrseismteonlceecurelaserrpveorisrisotfehnecpeardensearvvioruirseosf. ...
The sample was divided into two groups, those treated with pegylated Interferon/Ribavirin ((peg)INF/Rib) (standard of care for chronic hepatitis C patients according to German guidelines) and those without (identifi ed by ATC Code L03AB and J05AB04). Of these patients all ICD-10 diagnoses...
Patients with CHB were identified using ICD-9 codes (070.22. 070.23, 070.32, 070.33, 070.30 or 070.31) and were included if they were adults (≥18 years) with at least one inpatient or two outpatient non-rule-out claims (claims not associated with a diagnostic workup used to rule out ...
United States Patent Application 20110182858 Kind Code: A1 Abstract: The invention relates to the use of a silibinin component for the production of a medicament that is adapted for parenteral administration for the treatment of viral hepatitis, preferably of hepatitis B or C, in particular for ...
Methods: This was a cross-sectional study that utilised consecutive secondary data from internal medicine wards of seven public hospitals in Jakarta between 2011 and 2013. Eligibility criteria included patients over the age of 18 years and an ICD-10 diagnosis code of B15, acute hepatitis A. Case...
Data were extracted for hospitalizations with hepatitis E as defined by ICD‐9 codes 070.43 and 070.53 and ICD‐10 code B17.2. Of 208,462,242 hospitalizations from 2010–2015, we identified 960 hepatitis E hospitalizations. The hospitalization rate of hepatitis E was 3.7 per 10 million in 2010...